New Advances in Nanomaterial-Based Antiviral Strategies

Xu, X. C.; Zhang, J.; Liu, S.; Wang, C. H.; Wang, H. Y.; Fan, H. H.; Tong, Y. G.; Liu, H. Y.; Zhou, D. S.

Xu, X. C.; Zhang, J.; Liu, S.; Wang, C. H.; Wang, H. Y.; Fan, H. H.; Tong, Y. G.; Liu, H. Y.; Zhou, D. S..

Small Structures ; : 19, 2022.

Article in English | Web of Science | ID: covidwho-1802587

ABSTRACT

ABSTRACT

The ongoing coronavirus disease 2019 (COVID-19) pandemic and other major viral infectious diseases have become a significant threat to people's life and economic/social development. In recent years, with the development of nanotechnology, nanomaterial-based antiviral agents have been extensively studied. However, the clinical applications of antiviral nanomaterials are still limited. Herein, the recent advances in nanomaterial-based antiviral strategies, mainly including antiviral nanodrugs, drug nanocarriers, and nanovaccines, are summarized. The clinical challenges and prospects of nanomaterial-based antiviral strategies are also discussed.

Keywords

antiviral therapy; COVID-19; nanocarriers; nanodrugs; nanovaccines; h1n1 influenza-virus; silver nanoparticles; graphene oxide; gold; nanoparticles; beta-cyclodextrin; ribavirin prodrug; hiv-1 protease; inflexal(r) v; in-vitro; inhibition; Chemistry; Science & Technology - Other Topics; Materials Science

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: Web of Science Language: English Journal: Small Structures Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google